Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

Mustafa Karaca; Ece Salim; Mustafa Serkan Alemdar; Özge Deniz Karaca; Mustafa Özgür Arıcı

doi:10.12659/MSM.943750

28 March 2024: Clinical Research

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

Mustafa Karaca ^1ACDEF* , Ece Salim ^2ABDEF , Mustafa Serkan Alemdar ^3BDEF , Özge Deniz Karaca ^2BEF , Mustafa Özgür Arıcı ^3BDEF

DOI: 10.12659/MSM.943750

Med Sci Monit 2024; 30:e943750

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

View HTML version

Figure 3 Kaplan-Meier survival curve for OS by NLR groups. The 5-year OS rates were lower in the NLR >3.63 group but this difference was not statistically significant (P=0.077). NLR – neutrophil-to-lymphocyte ratio; OS – overall survival. We used SPSS 23.0 software package (IBM Corp., Armonk, NY) to draw this figure.

Back to the Article

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

Your Privacy